Alosetron Tablet
Product Images NDC 63629-2518

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Alosetron (NDC 63629-2518). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (371e1085 3e61 4192 Ab8b 883ba90639f2 01)

Chemical structure of alosetron hydrochloride as depicted by a molecular diagram with labeled atoms and bonds.*

FDA Label Image

Figure 1 (371e1085 3e61 4192 Ab8b 883ba90639f2 02)

Bar chart comparing percent of patients between placebo and Alosetron tablets 1 mg B.I.D. groups across Studies 1 & 2 and Studies 3 & 4. The chart shows higher patient percentages in the Alosetron groups compared to placebo for both study sets.*

FDA Label Image

Label (Lbl636292518)

Alosetron Tablets, USP 1 mg oral tablets label by Bryant Ranch Prepack. The label includes the NDC 63629-2518-1, manufacturer logo BRP Pharmaceuticals, and states the package contains 30 tablets. It provides storage instructions at 20° to 25°C and child-resistant packaging requirements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.